Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
We live in a time of increased health care challenges within a milieu of ongoing COVID-19, climate change, war, gun violence, racial and ethnic discrimination, political divisions, and ongoing financial challenges to health care systems and financing. Amidst this background, the JAMA Internal Medicine editors came together to renew our commitment to publishing evidence to inform and improve health and health care. Our commitment is captured in our new mission statement: "To advance the equitable, person-centered, and evidence-based practice of internal medicine through publication of scientifically rigorous, innovative, and inclusive research, review, and commentary that informs dialogue and action with clinical, public health, and policy impact." 1 In direct alignment with this mission, published articles have addressed meaningful themes, such as the treatment and outcomes of COVID-19, benefits and challenges of artificial intelligence in health care, importance of prevention in health care, association of social determinants of health and violence with health, and lack of equity in health care. Our articles, such as those featured in the Table, 2-6 have informed, raised awareness, and proposed solutions. We prioritize articles that have strong clinical relevance and the potential to change clinical practice. 7 Our year-end statistics reflect the broad global effect and reach of JAMA Internal Medicine. Despite the anticipated decrease in COVID-19 articles and the associated deflation in the Journal Impact Factor, the journal performance has remained robust. Submissions remain steady at 3419 received in 2023, with acceptance rates of 13% overall and 6% for original research articles. Our review times remain expeditious, with time to initial decision without peer review at a median of 2 days and time to first decision with peer review at a median of 39 days. Approximately 350 000 receive our weekly electronic Table of Contents, and there were more than 15 million article views and downloads in 2023. The 2022 Journal Impact Factor was 39, placing JAMA Internal Medicine among the leading journals in internal medicine worldwide.During the 6 months since I took the helm at JAMA Internal Medicine, we have introduced new themes, series, and article types. We have already published articles in our new theme of Climate Change and Health. We will soon be issuing 2 new calls for papers in 2024. Our first call on the theme of Women's Health 8 (led by Deborah Grady, MD, MPH) highlights a relatively neglected scientific area of fundamental importance to health worldwide. Our second call on Innovations in Clinical Trials (led by Tracy Wang, MD, MHS, MSc, and Giselle Corbie, MD, MSc) will highlight our interest in rigorous clinical trials relevant to internal medicine, with particular emphasis on nonpharmacologic and behavioral interventions, innovative trial designs, and pragmatic trials that promote equity.We are deeply committed to addressing racism and ageism in medicine, health care, and public health globally. Raegan W.
We live in a time of increased health care challenges within a milieu of ongoing COVID-19, climate change, war, gun violence, racial and ethnic discrimination, political divisions, and ongoing financial challenges to health care systems and financing. Amidst this background, the JAMA Internal Medicine editors came together to renew our commitment to publishing evidence to inform and improve health and health care. Our commitment is captured in our new mission statement: "To advance the equitable, person-centered, and evidence-based practice of internal medicine through publication of scientifically rigorous, innovative, and inclusive research, review, and commentary that informs dialogue and action with clinical, public health, and policy impact." 1 In direct alignment with this mission, published articles have addressed meaningful themes, such as the treatment and outcomes of COVID-19, benefits and challenges of artificial intelligence in health care, importance of prevention in health care, association of social determinants of health and violence with health, and lack of equity in health care. Our articles, such as those featured in the Table, 2-6 have informed, raised awareness, and proposed solutions. We prioritize articles that have strong clinical relevance and the potential to change clinical practice. 7 Our year-end statistics reflect the broad global effect and reach of JAMA Internal Medicine. Despite the anticipated decrease in COVID-19 articles and the associated deflation in the Journal Impact Factor, the journal performance has remained robust. Submissions remain steady at 3419 received in 2023, with acceptance rates of 13% overall and 6% for original research articles. Our review times remain expeditious, with time to initial decision without peer review at a median of 2 days and time to first decision with peer review at a median of 39 days. Approximately 350 000 receive our weekly electronic Table of Contents, and there were more than 15 million article views and downloads in 2023. The 2022 Journal Impact Factor was 39, placing JAMA Internal Medicine among the leading journals in internal medicine worldwide.During the 6 months since I took the helm at JAMA Internal Medicine, we have introduced new themes, series, and article types. We have already published articles in our new theme of Climate Change and Health. We will soon be issuing 2 new calls for papers in 2024. Our first call on the theme of Women's Health 8 (led by Deborah Grady, MD, MPH) highlights a relatively neglected scientific area of fundamental importance to health worldwide. Our second call on Innovations in Clinical Trials (led by Tracy Wang, MD, MHS, MSc, and Giselle Corbie, MD, MSc) will highlight our interest in rigorous clinical trials relevant to internal medicine, with particular emphasis on nonpharmacologic and behavioral interventions, innovative trial designs, and pragmatic trials that promote equity.We are deeply committed to addressing racism and ageism in medicine, health care, and public health globally. Raegan W.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.